Compare Axogen Inc (AXGN) vs Rocket Lab USA Inc (RKLB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Axogen Inc vs Rocket Lab USA Inc — how do they compare? Axogen Inc trades at $38.68 (market cap $2.06B), while Rocket Lab USA Inc trades at $78.53 (market cap $49.24B). The key difference: Rocket Lab USA Inc is far larger — about 23.9× Axogen Inc's market cap, and Axogen Inc is trading nearer its 52-week high, Rocket Lab USA Inc nearer its low. Which is the better fit depends on your goals.
| AXGN | RKLB | |
|---|---|---|
Market Cap | $2.06B | $49.24B |
Sector | Technology | Technology |
52-Week High | $46.19 | $150.23 |
52-Week Low | $11.28 | $39.48 |
Enterprise Value | $1.98B | $48.00B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AXGN trades at $39.49, down 2.69% today, with a bearish technical signal despite recent earnings volatility. The company reported mixed quarterly results with Q3 2025 beating estimates but Q1 2026 missing expectations. Strong analyst sentiment persists with 84% buy ratings and a $47.60 consensus price target, though negative profit margins and recent technical weakness create uncertainty.
The outlook remains cautiously optimistic given strong institutional support and reimbursement progress, but investors face risks from persistent losses and competitive pressures. The stock's current position near support at $39 suggests potential for recovery if upcoming Q2 earnings meet or exceed the $0.09 EPS estimate.
Rocket Lab (RKLB) trades at $76.73, down 5.32% over 24 hours, testing key support near $75 amid a bearish technical trend. The company reported Q1 2026 EPS of -$0.02, beating expectations, while revenue reached $601.80M in 2025 with a net loss of -$198.21M. Analyst sentiment remains bullish with a $119.10 consensus price target, supported by recent strategic moves like the Iridium acquisition announced July 13, 2026.
The outlook hinges on execution of growth initiatives and path to profitability, with risks including high cash burn and competitive pressures. Upside potential exists if operational efficiencies improve and satellite revenue scales, but investors face volatility from negative margins and sector headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Axogen Inc
Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →About Rocket Lab USA Inc
Rocket Lab USA, Inc. is an aerospace manufacturer and small-satellite launch service provider. The company specializes in developing rockets for orbital launch, including its flagship *Electron* vehicle, and is developing the next-generation, reusable *Neutron* rocket. Beyond launch services, Rocket Lab also offers satellite design, manufacturing, and spacecraft component solutions, positioning itself as an end-to-end provider for the space industry.
Read more on RKLB →
